Science Explorer Interactive view Map
Company · Épalinges · Switzerland

Adc Therapeutics (Switzerland)

adctherapeutics.comROR OpenAlex
Research works
34
▲ 315% vs 2013–17
Citations
308
9.0 per fractional work
Top-10% rate
6.2%
record average 16.5%
Open access
52%
world 28%

Not ranked overall: Adc Therapeutics (Switzerland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.40× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.87× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 8.73× its world share, 2 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 0.68× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.41× its world share, 0 worksChemistryComputer Science: 0.11× its world share, 0 worksComputer ScienceEngineering: 0.08× its world share, 0 worksEngineeringEnvironmental Science: 0.22× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.48× its world share, 0 worksMaterials ScienceHealth Professions: 0.07× its world share, 0 worksHealth ProfessionsMedicine: 3.14× its world share, 12 worksMedicineBusiness, Management and Accounting: 1.04× its world share, 1 worksBusiness, Management…Decision Sciences: 0.25× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.29× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.15× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 8.7×. Every wedge is a field page.

Which keywords describe research at Adc Therapeutics (Switzerland)?

By fractional works in all years, weighted toward what it does more of than the world: Lymphoma, Cancer Immunotherapy, Rituximab, Immunotherapy, Leukemia, CAR T Cells, Chimeric Antigen Receptor and Prognostic Factors.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 22 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 22 words, with their numbers
  1. Lymphoma6▲ 120×3 topics
  2. Cancer Immunotherapy5▲ 103×3 topics
  3. Rituximab5▲ 90×3 topics
  4. Immunotherapy4▲ 20×7 topics
  5. Leukemia4▲ 179×2 topics
  6. CAR T Cells4▲ 261×1 topic
  7. Chimeric Antigen Receptor4▲ 261×1 topic
  8. Prognostic Factors3▲ 20×6 topics
  9. Glycosylation3▲ 38×3 topics
  10. Chronic Lymphocytic Leukemia3▲ 162×1 topic
  11. Genomic Aberrations3▲ 162×1 topic
  12. Monoclonal Antibodies3▲ 53×2 topics
  13. Fc Receptors2▲ 71×1 topic
  14. PET Imaging2▲ 33×3 topics
  15. Therapeutic Antibodies2▲ 55×1 topic
  16. Classification2▲ 17×1 topic
  17. Molecular Profiling2▲ 52×1 topic
  18. Chemotherapy2▲ 7.1×3 topics
  19. Monoclonal Antibody1▲ 52×2 topics
  20. Antigen Presentation1▲ 30×2 topics
  21. Breast Cancer1▲ 11×2 topics
  22. Cancer Therapy1▲ 4.7×7 topics

Which research topics does Adc Therapeutics (Switzerland) publish most on?

By volume in 2022–2025: Chronic Lymphocytic Leukemia Research, CAR-T cell therapy research, Monoclonal and Polyclonal Antibodies Research and Lymphoma Diagnosis and Treatment.

Chronic Lymphocytic Leuk…2Chronic Lymphocytic Leukemia Research: 2 fractional worksCAR-T cell therapy resea…2CAR-T cell therapy research: 2 fractional worksMonoclonal and Polyclonal Antibodies Research: 2 fractional worksLymphoma Diagnosis and T…2Lymphoma Diagnosis and Treatment: 2 fractional worksImmunotherapy and Immune…1Immunotherapy and Immune Responses: 1 fractional worksBiomedical Ethics and Regulation: 0 fractional worksTransplantation: Methods and Outcomes: 0 fractional worksChronic Myeloid Leukemia Treatments: 0 fractional worksProtein Degradation and Inhibitors: 0 fractional worksPlant Virus Research Studies: 0 fractional works
GeneticsOncologyRadiology, Nuclear Medicine and ImagingPathology and Forensic Medicine6 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Chronic Lymphocytic Leukemia Research Genetics 2 works
  2. 2 CAR-T cell therapy research Oncology 2 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
  4. 4 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 2 works
  5. 5 Immunotherapy and Immune Responses Immunology 1 works
  6. 6 Biomedical Ethics and Regulation Physiology 0 works
  7. 7 Transplantation: Methods and Outcomes Surgery 0 works
  8. 8 Chronic Myeloid Leukemia Treatments Hematology 0 works
  9. 9 Protein Degradation and Inhibitors Molecular Biology 0 works
  10. 10 Plant Virus Research Studies Plant Science 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available51.5%not open48.5%

World: 28% of research is openly available.

with international co-authors61.6%domestic only38.4%

World: 19% is written across borders.

How has Adc Therapeutics (Switzerland)'s research output changed?

Output in 2018–2022 was 315% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Épalinges

All research institutions in Épalinges

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.